
|Articles|June 1, 2004
Physician extenders can handle lion's share of ALA-PDT work
Dallas - What is the nurse's role in the administration of ALA-PDT (5-aminolevulinic acid[ALA]-photodynamic therapy [PDT])? At Gold Skin Care Center in Nashville, the better question might be: What is the physician's role in offering this therapy, which involves the use of a laser or light source plus an enhancer, ALA HCl topical solution, 20 percent, (Levulan, DUSA Pharmaceuticals)?
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Oruka Reports Positive Interim Phase 1 Data for ORKA-002, Advances ORKA-001
2
French Early Access Data on Dupilumab in Pediatric Atopic Dermatitis
3
Recludix Pharma’s REX-8756 for Type 2 Inflammatory Diseases Enters First Human Trials
4
Alpha Tau Submits First PMA Module to FDA for Novel cSCC Treatment, Alpha DaRT
5


















